HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert E Humphreys Selected Research

Pharmaceutical Preparations

4/2004Immunotherapy of cancer by antisense inhibition of Ii protein, an immunoregulator of antigen selection by MHC class II molecules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert E Humphreys Research Topics

Disease

8Neoplasms (Cancer)
05/2007 - 10/2003
2Communicable Diseases (Infectious Diseases)
12/2006 - 01/2006
1Human Influenza (Influenza)
12/2006
1Melanoma (Melanoma, Malignant)
07/2005
1Breast Neoplasms (Breast Cancer)
06/2004

Drug/Important Bio-Agent (IBA)

7EpitopesIBA
05/2007 - 04/2004
7Peptides (Polypeptides)IBA
05/2007 - 05/2004
5invariant chain (Ii-Key)IBA
05/2007 - 06/2004
4Protein Subunit VaccinesIBA
05/2007 - 06/2004
4VaccinesIBA
12/2006 - 06/2004
4Proteins (Proteins, Gene)FDA Link
06/2004 - 10/2003
3Histocompatibility Antigens Class IIIBA
06/2004 - 04/2004
3AntigensIBA
06/2004 - 04/2004
2Histocompatibility Antigens Class IIBA
06/2004 - 05/2004
1Neoplasm Antigens (Tumor Antigens)IBA
06/2004
1HLA-DR Antigens (HLA-DR)IBA
05/2004
1Pharmaceutical PreparationsIBA
04/2004
1Interleukin-2 (IL2)IBA
10/2003
1MHC class II transactivator proteinIBA
10/2003

Therapy/Procedure

4Immunotherapy
01/2006 - 10/2003
1Therapeutics
04/2004
1Injections
10/2003